Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating... see more

CSE:BRAX - Post Discussion

Braxia Scientific Corp > Braxia and Newcoin
View:
Post by cautiousguy on Apr 15, 2024 6:43pm

Braxia and Newcoin

Both fallen by the wayside.  Not a peep or a pump.
Comment by Clayton13 on Apr 16, 2024 4:30pm
Calm before the storm - with ai shorting the hell out of investors money better to keep all confidential on the phase 2 approvals and sale to big pharma 
Comment by cautiousguy on Jul 18, 2024 10:24pm
Hey Clayton 13 is still part of the plan.....are we in the calm phase?  Is newcon in here with us? 
Comment by cautiousguy on Apr 17, 2024 10:36am
Ha ha ha ... there you are.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities